GSK-spinoff Haleon forecasts 2023 organic revenue growth at top-end of view
(Reuters) – Consumer healthcare group Haleon expects 2023 organic revenue growth towards the upper end of its 4%-6% forecast, it said on Thursday, on strong …
gsk-spinoff